
varicose veins
(166 in 5-year
follow-up); GSV

EVLA (n ¼ 57);
HL&S
(n ¼ 50)

UGFS with
physiciancompounded
foam (1%
polidocanol;
1% or 3%
sodium
tetradecyl
sulfate; n ¼ 59)

At 5 years, UGFS had
lowest occlusion rate
